Talk:Body mass excess: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 11: Line 11:
::::* https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787246?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=mthlyforyou&utm_term=010222
::::* https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787246?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=mthlyforyou&utm_term=010222
::::* https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038834
::::* https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038834
::::* Shi Q, Wang Y, Hao Q, Vandvik PO, Guyatt G, Li J, Chen Z, Xu S, Shen Y, Ge L, Sun F, Li L, Yu J, Nong K, Zou X, Zhu S, Wang C, Zhang S, Qiao Z, Jian Z, Li Y, Zhang X, Chen K, Qu F, Wu Y, He Y, Tian H, Li S. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2021 Dec 8:S0140-6736(21)01640-8. doi: 10.1016/S0140-6736(21)01640-8. Epub ahead of print. PMID: 34895470 - https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01640-8/fulltext?dgcid=raven_jbs_etoc_email

Revision as of 13:21, 15 January 2022

References

Cookies help us deliver our services. By using our services, you agree to our use of cookies.